Pan Chen

ORCID: 0000-0003-0271-2725 · 6 papers in corpus · active 2018-2020

Study types

  • article 5
  • other 1

Condition tags

  • endometriosis 6
article 2020
HEAT SHOCK PROTEIN 90 INHIBITOR 17-AAG SUPPRESSES THE GROWTH OF ENDOMETRIOSIS IN VITRO AND IN VIVO BY INHIBITING ESTROGEN RECEPTOR TRANSCRIPTIONAL ACTIVITY
·doi:10.1016/j.fertnstert.2020.08.575
article 2020
THE SUPPRESSIVE EFFECT OF CELASTROL ON GROWTH OF ENDOMETRIOSIS IN VITRO IS ASSOCIATED WITH ANTAGONISM OF ESTROGEN RECEPTOR ACTIVITY
·doi:10.1016/j.fertnstert.2020.09.096
other 2019
Correction to: Endometrium metabolomic profiling reveals potential biomarkers for diagnosis of endometriosis at minimal-mild stages
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-019-0532-5

The authors regret that the incorrect identification of "omega-3 arachidonic acid" published in the original manuscript [1].

article 2019
Suppressive Effects of Ursolic Acid on Human Endometriotic Stromal Cells Survival
Gynecologic and obstetric investigation ·doi:10.1159/000502258

BACKGROUND/AIMS: The identification of new compound candidates for endometriosis treatment is needed. Cyclooxygenase-2 (COX-2) is considered a crucial target to control the progress and recurrence of endometriosis. Here, we identified ursol…

article 2018
Discovery of Phosphatidic Acid, Phosphatidylcholine, and Phosphatidylserine as Biomarkers for Early Diagnosis of Endometriosis
Frontiers in physiology ·doi:10.3389/fphys.2018.00014

The sensitivity and specificity of clinical diagnostic indicators and non-invasive diagnostic methods for endometriosis at early stage is not optimal. Previous studies demonstrated that abnormal lipid metabolism was involved in the patholog…

article 2018
Endometrium metabolomic profiling reveals potential biomarkers for diagnosis of endometriosis at minimal-mild stages
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-018-0360-z

BACKGROUND: The sensitivity and specificity of non-invasive diagnostic methods for endometriosis, especially at early stages, are not optimal. The clinical diagnostic indicator cancer antigen 125 (CA125) performs poorly in the diagnosis of …